Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4

David A. Lane, J. J. Denton, A. Flynn, +2

Biochemical Journal

Bioorganic ChemistryAntithrombin Iii MoleculeImmunologyGlycobiologyPolysaccharide +20

Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4.

David A. Lane, Gunnar Pejler, A. Flynn, +2

Journal of Biological Chemistry

GlycobiologyImmunologyHeparin-related SaccharidesPolysaccharideBioanalysis +16

Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin

David A. Lane, A. Flynn, H. Ireland, +3

British Journal of Haematology

Antithrombotic Properties of Dermatan Sulphate (MF 701) in Haemodialysis for Chronic Renal Failure

K E Ryan, David A. Lane, A. Flynn, +4

Thrombosis and Haemostasis

DialysisGlycobiologyDialysis TherapyPharmacotherapyThrombosis +18

A Low-Molecular-Weight Heparin (Kabi 2165, 'Fragmin') in Repeated Use for Haemodialysis: Prevention of Clotting and Prolongation of the Venous Compression Time in Comparison with Commercial Unfractionated Heparin

E. Anastassiades, H. Ireland, A. Flynn, +2

Nephrology Dialysis Transplantation

Antithrombin Sheffield: amino acid substitution at the reactive site (Arg393 to His) causing thrombosis

David A. Lane, A. Flynn, Vincenzo Di Marzo, +5

British Journal of Haematology

A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin.

E. Anastassiades, David A. Lane, H Ireland, +2

PubMed

Crossover TrialDialysisDialysis TherapyPharmacotherapyHemodialysis Patients +19

Dose Finding Study of a Low Molecular Weight Heparin, Innohep, in Haemodialysis

K E Ryan, David A. Lane, A. Flynn, +3

Thrombosis and Haemostasis

Bolus InjectionsDialysis TherapyPharmacotherapyDose Finding StudyThrombosis +17

Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis

David A. Lane, G.D.O. Lowe, A. Flynn, +2

British Journal of Haematology

On the Evaluation of Heparin and Low Molecular Weight Heparin in Haemodialysis for Chronic Renal Failure

David A. Lane, A. Flynn, H Ireland, +2

Pathophysiology of Haemostasis and Thrombosis

Kabi 2165DialysisDialysis TherapyThrombosisVisual Inspection +16